Quantcast

Latest ifosfamide Stories

2015-05-04 08:30:38

Combination Clinical Trial Data Showing Impressive Activity in Bone Cancer and Other Sarcomas LOS ANGELES, May 4, 2015 /PRNewswire/ -- CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical

2010-04-21 06:30:00

NEW YORK, April 21 /PRNewswire/ -- The Kristen Ann Carr Fund has awarded a grant to Jonathan Lewis, MD, PhD, Chief Executive Officer and Chief Medical Officer of ZIOPHARM Oncology, Inc., which will fund translational work at the Memorial Sloan-Kettering Cancer Center and the Albert Einstein College of Medicine in New York City, for the development of a novel treatment for pediatric sarcoma.

2010-04-19 07:00:00

SCHAUMBURG, Ill., April 19 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced the Company has received U.S.

2008-10-16 12:00:05

Ziopharm Oncology, a biopharmaceutical company, has announced that the European Medicines Agency's Committee for Orphan Medicinal Products has issued a positive opinion regarding the company's application for orphan medicinal product designation for palifosfamide in the treatment of soft tissue sarcoma.


Word of the Day
  • an ornament or knob in the shape of a flower
  • In architecture, a floral ornament; specifically, the large conventional flower usually placed in the center of the abacus of a Corinthian capital or classic ceiling-caisson; also, the floreated termination of a Gothic finial.
[ "The word 'fleuron' comes from French."]